Literature DB >> 17266174

Increased proliferation of CD8+ T cells in SAP-deficient mice is associated with impaired activation-induced cell death.

Gang Chen1, Albert K Tai, Miao Lin, Francesca Chang, Cox Terhorst, Brigitte T Huber.   

Abstract

Defective signaling lymphocyte activation molecule (SLAM)-associated protein (SAP) is responsible for the human X-linked lymphoproliferative syndrome. Defects in T helper 2, natural killer, natural killer T and B cells have been demonstrated in SAP-deficient humans and mice, and increased proliferation of CD8+ T cells has been observed. In the current study, we investigated the properties of CD8+ T cell proliferation and activation-induced cell death (AICD), using OT-I T cell receptor (TCR)-transgenic mice on either wild-type (WT) or SAP-/- background. Interestingly, we found that ovalbumin peptide-activated SAP-/- CD8+ T cells have lower AICD compared to their WT counterparts. Furthermore, the induction of p73, a key mediator of TCR-induced apoptosis through the mitochondrial apoptotic pathway, was significantly reduced at both the mRNA and protein levels in the activated mutant cells. Meanwhile, a reduced level of activated caspase 9 was observed in the mutant cells. We conclude that reduced AICD in activated SAP-/- CD8+ T cells is associated with impaired p73 induction, indicating that the initiation of the mitochondrial apoptotic pathway might be impaired. Our data demonstrate an intrinsic defect in SAP-/- CD8+ T cells and shed light on the increased responsiveness of CD8+ T cells in SAP-/- mice.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17266174     DOI: 10.1002/eji.200636417

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  20 in total

1.  CD84 is a survival receptor for CLL cells.

Authors:  I Binsky-Ehrenreich; A Marom; M C Sobotta; L Shvidel; A Berrebi; I Hazan-Halevy; S Kay; A Aloshin; I Sagi; D M Goldenberg; L Leng; R Bucala; Y Herishanu; M Haran; I Shachar
Journal:  Oncogene       Date:  2013-02-25       Impact factor: 9.867

Review 2.  SLAM family receptors and the SLAM-associated protein (SAP) modulate T cell functions.

Authors:  Cynthia Detre; Marton Keszei; Xavier Romero; George C Tsokos; Cox Terhorst
Journal:  Semin Immunopathol       Date:  2010-02-10       Impact factor: 9.623

Review 3.  SLAM-family receptors: immune regulators with or without SAP-family adaptors.

Authors:  André Veillette
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-03       Impact factor: 10.005

4.  Epstein-Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8-9 September 2008.

Authors:  J I Cohen; H Kimura; S Nakamura; Y-H Ko; E S Jaffe
Journal:  Ann Oncol       Date:  2009-06-10       Impact factor: 32.976

5.  Towards mimicking short linear peptide motifs: identification of new mixed α,β-peptidomimetic ligands for SLAM-Associated Protein (SAP) by confocal on-bead screening.

Authors:  Martin Hintersteiner; Andrew J Knox; Gemma Mudd; Manfred Auer
Journal:  J Chem Biol       Date:  2012-01-03

6.  The proapoptotic function of SAP provides a clue to the clinical picture of X-linked lymphoproliferative disease.

Authors:  Noémi Nagy; Liudmila Matskova; Loránd L Kis; Ulf Hellman; George Klein; Eva Klein
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-01       Impact factor: 11.205

Review 7.  Genetic defects of apoptosis and primary immunodeficiency.

Authors:  Helen C Su; Michael J Lenardo
Journal:  Immunol Allergy Clin North Am       Date:  2008-05       Impact factor: 3.479

8.  Restimulation-induced apoptosis of T cells is impaired in patients with X-linked lymphoproliferative disease caused by SAP deficiency.

Authors:  Andrew L Snow; Rebecca A Marsh; Scott M Krummey; Philip Roehrs; Lisa R Young; Kejian Zhang; Jack van Hoff; Deepali Dhar; Kim E Nichols; Alexandra H Filipovich; Helen C Su; Jack J Bleesing; Michael J Lenardo
Journal:  J Clin Invest       Date:  2009-09-14       Impact factor: 14.808

9.  FOXP3 renders activated human regulatory T cells resistant to restimulation-induced cell death by suppressing SAP expression.

Authors:  Gil Katz; Kelsey Voss; Toria F Yan; Yong Chan Kim; Robert L Kortum; David W Scott; Andrew L Snow
Journal:  Cell Immunol       Date:  2018-02-12       Impact factor: 4.868

10.  Inhibition of diacylglycerol kinase α restores restimulation-induced cell death and reduces immunopathology in XLP-1.

Authors:  Elisa Ruffo; Valeria Malacarne; Sasha E Larsen; Rupali Das; Laura Patrussi; Christoph Wülfing; Christoph Biskup; Senta M Kapnick; Katherine Verbist; Paige Tedrick; Pamela L Schwartzberg; Cosima T Baldari; Ignacio Rubio; Kim E Nichols; Andrew L Snow; Gianluca Baldanzi; Andrea Graziani
Journal:  Sci Transl Med       Date:  2016-01-13       Impact factor: 17.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.